Predictors of outcome after non-surgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy

被引：0
|
作者：
Chang, SM [1 ]
Lakkis, NM [1 ]
Spencer, WH [1 ]
Nagueh, SF [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2255
引用
收藏
页码：492 / 493
页数：2
相关论文
共 50 条
  • [31] Outcome of elderly patients after alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    Jahnlova, D.
    Tomasov, P.
    Veselka, J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 367 - 367
  • [32] Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest for the septal coronary anatomy
    Steggerda, R. C.
    Balt, J. C.
    Damman, K.
    van den Berg, M. P.
    ten Berg, J. M.
    NETHERLANDS HEART JOURNAL, 2013, 21 (11) : 504 - 509
  • [33] Tumor necrosis factor x is a potential mediator of pressure overload injury in patients with hypertrophic obstructive cardiomyopathy:: Effects of non-surgical septal reduction
    Torre-Amione, G
    Stetson, SS
    Youker, KA
    Lakkis, NM
    Spencer, WH
    Entman, ML
    Nagueh, SF
    CIRCULATION, 1999, 100 (18) : 128 - 128
  • [34] Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest for the septal coronary anatomy
    R. C. Steggerda
    J. C. Balt
    K. Damman
    M. P. van den Berg
    J. M. ten Berg
    Netherlands Heart Journal, 2013, 21 : 504 - 509
  • [35] CYANOACRYLATE FOR NONSURGICAL SEPTAL REDUCTION THERAPY IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Oto, A.
    Aytemir, K.
    Okutucu, S.
    Cil, B.
    Peynircioglu, B.
    Kaya, E. B.
    Deniz, A.
    Evranos, B.
    Sahiner, L.
    Kabakci, G.
    Tokgozoglu, L.
    Ozkutlu, H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S70 - S71
  • [36] Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy:: early and 6 months follow-up
    Durand, Eric
    Mousseaux, Elie
    Coste, Pierre
    Pilliere, Remy
    Dubourg, Olivier
    Trinquart, Ludovic
    Chatellier, Gilles
    Hagege, Albert
    Desnos, Michel
    Lafont, Antoine
    EUROPEAN HEART JOURNAL, 2008, 29 (03) : 348 - 355
  • [37] Midterm Outcome After Septal Myectomy and Medical Therapy in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy
    Sun, Jiejun
    Liang, Lin
    Li, Peijin
    Jiang, Tengyong
    Yu, Xianpeng
    Ren, Changwei
    Dong, Ran
    He, Jiqiang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [38] Left ventricular remodelling after nonsurgical septal reduction therapy for obstructive hypertrophic cardiomyopathy
    Nagueh, SF
    Spencer, WH
    Lakkis, NM
    Zoghbi, WA
    Kleiman, NS
    Killip, DM
    Roberts, R
    Quinones, MA
    CIRCULATION, 1997, 96 (08) : 3277 - 3277
  • [39] Comparison of Surgical Ventricular Septal Reduction to Alcohol Septal Ablation Therapy in Patients with Hypertrophic Cardiomyopathy
    Bourque, Catherine
    Reant, Patricia
    Bernard, Anne
    Leroux, Lionel
    Bonnet, Guillaume
    Pernot, Mathieu
    Bisson, Arnaud
    Herbert, Julien
    Saint-Etienne, Christophe
    Lafitte, Stephane
    Fauchier, Laurent
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 172 : 109 - 114
  • [40] Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction
    Desai, Milind Y.
    Owens, Anjali
    Wolski, Kathy
    Geske, Jeffrey B.
    Saberi, Sara
    Wang, Andrew
    Sherrid, Mark
    Cremer, Paul C.
    Lakdawala, Neal K.
    Tower-Rader, Albree
    Fermin, David
    Naidu, Srihari S.
    Smedira, Nicholas G.
    Schaff, Hartzell
    McErlean, Ellen
    Sewell, Christina
    Zhong, Yue
    Wyrwich, Kathleen W.
    Lampl, Kathy L.
    Sehnert, Amy J.
    Nissen, Steven E.
    Spertus, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (11) : 1041 - 1045
12345